The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Anti-Smoking Products-Global Market Insights and Sales Trends 2025
Synopsis
The smoking cessation and nicotine de-addiction market is categorized into three major segments including drug therapy, Nicotine Replacement Therapy (NRT), and Electronic cigarettes (E-cigarettes).
The global Anti-Smoking Products market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Anti-Smoking Products in various end use industries. The expanding demands from the Smokers aged 18–24, Smokers aged 25–44, Smokers aged 45–64 and Smokers aged 65 years or older, are propelling Anti-Smoking Products market. Nicotine Replacement Therapy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Drug therapy segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Anti-Smoking Products market, driven by demand from China, the second largest economy with some signs of stabilising, the Anti-Smoking Products market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Anti-Smoking Products, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Anti-Smoking Products market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Anti-Smoking Products market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Anti-Smoking Products sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Anti-Smoking Products covered in this report include Pfizer, Cipla, Novartis International, GSK, Takeda pharmaceutical, McNeil AB, Revolymer plc, Imperial Tobacco and Elder Pharma, etc.
The global Anti-Smoking Products market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Cipla
Novartis International
GSK
Takeda pharmaceutical
McNeil AB
Revolymer plc
Imperial Tobacco
Elder Pharma
NJOY
VMR products
Lorillard
VaporCorp
Global Anti-Smoking Products market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Anti-Smoking Products market, Segment by Type:
Nicotine Replacement Therapy
Drug therapy
E-cigarettes
Global Anti-Smoking Products market, by Application
Smokers aged 18–24
Smokers aged 25–44
Smokers aged 45–64
Smokers aged 65 years or older
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Anti-Smoking Products companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The smoking cessation and nicotine de-addiction market is categorized into three major segments including drug therapy, Nicotine Replacement Therapy (NRT), and Electronic cigarettes (E-cigarettes).
The global Anti-Smoking Products market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Anti-Smoking Products in various end use industries. The expanding demands from the Smokers aged 18–24, Smokers aged 25–44, Smokers aged 45–64 and Smokers aged 65 years or older, are propelling Anti-Smoking Products market. Nicotine Replacement Therapy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Drug therapy segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Anti-Smoking Products market, driven by demand from China, the second largest economy with some signs of stabilising, the Anti-Smoking Products market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Anti-Smoking Products, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Anti-Smoking Products market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Anti-Smoking Products market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Anti-Smoking Products sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Anti-Smoking Products covered in this report include Pfizer, Cipla, Novartis International, GSK, Takeda pharmaceutical, McNeil AB, Revolymer plc, Imperial Tobacco and Elder Pharma, etc.
The global Anti-Smoking Products market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Cipla
Novartis International
GSK
Takeda pharmaceutical
McNeil AB
Revolymer plc
Imperial Tobacco
Elder Pharma
NJOY
VMR products
Lorillard
VaporCorp
Global Anti-Smoking Products market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Anti-Smoking Products market, Segment by Type:
Nicotine Replacement Therapy
Drug therapy
E-cigarettes
Global Anti-Smoking Products market, by Application
Smokers aged 18–24
Smokers aged 25–44
Smokers aged 45–64
Smokers aged 65 years or older
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Anti-Smoking Products companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Anti-Smoking Products
1.1 Anti-Smoking Products Market Overview
1.1.1 Anti-Smoking Products Product Scope
1.1.2 Anti-Smoking Products Market Status and Outlook
1.2 Global Anti-Smoking Products Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Anti-Smoking Products Market Size by Region (2018-2029)
1.4 Global Anti-Smoking Products Historic Market Size by Region (2018-2023)
1.5 Global Anti-Smoking Products Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Anti-Smoking Products Market Size (2018-2029)
1.6.1 North America Anti-Smoking Products Market Size (2018-2029)
1.6.2 Europe Anti-Smoking Products Market Size (2018-2029)
1.6.3 Asia-Pacific Anti-Smoking Products Market Size (2018-2029)
1.6.4 Latin America Anti-Smoking Products Market Size (2018-2029)
1.6.5 Middle East & Africa Anti-Smoking Products Market Size (2018-2029)
2 Anti-Smoking Products Market by Type
2.1 Introduction
2.1.1 Nicotine Replacement Therapy
2.1.2 Drug therapy
2.1.3 E-cigarettes
2.2 Global Anti-Smoking Products Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Anti-Smoking Products Historic Market Size by Type (2018-2023)
2.2.2 Global Anti-Smoking Products Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Anti-Smoking Products Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Anti-Smoking Products Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Anti-Smoking Products Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Anti-Smoking Products Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Anti-Smoking Products Revenue Breakdown by Type (2018-2029)
3 Anti-Smoking Products Market Overview by Application
3.1 Introduction
3.1.1 Smokers aged 18–24
3.1.2 Smokers aged 25–44
3.1.3 Smokers aged 45–64
3.1.4 Smokers aged 65 years or older
3.2 Global Anti-Smoking Products Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Anti-Smoking Products Historic Market Size by Application (2018-2023)
3.2.2 Global Anti-Smoking Products Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Anti-Smoking Products Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Anti-Smoking Products Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Anti-Smoking Products Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Anti-Smoking Products Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Anti-Smoking Products Revenue Breakdown by Application (2018-2029)
4 Anti-Smoking Products Competition Analysis by Players
4.1 Global Anti-Smoking Products Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-Smoking Products as of 2022)
4.3 Date of Key Players Enter into Anti-Smoking Products Market
4.4 Global Top Players Anti-Smoking Products Headquarters and Area Served
4.5 Key Players Anti-Smoking Products Product Solution and Service
4.6 Competitive Status
4.6.1 Anti-Smoking Products Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Pfizer
5.1.1 Pfizer Profile
5.1.2 Pfizer Main Business
5.1.3 Pfizer Anti-Smoking Products Products, Services and Solutions
5.1.4 Pfizer Anti-Smoking Products Revenue (US$ Million) & (2018-2023)
5.1.5 Pfizer Recent Developments
5.2 Cipla
5.2.1 Cipla Profile
5.2.2 Cipla Main Business
5.2.3 Cipla Anti-Smoking Products Products, Services and Solutions
5.2.4 Cipla Anti-Smoking Products Revenue (US$ Million) & (2018-2023)
5.2.5 Cipla Recent Developments
5.3 Novartis International
5.3.1 Novartis International Profile
5.3.2 Novartis International Main Business
5.3.3 Novartis International Anti-Smoking Products Products, Services and Solutions
5.3.4 Novartis International Anti-Smoking Products Revenue (US$ Million) & (2018-2023)
5.3.5 GSK Recent Developments
5.4 GSK
5.4.1 GSK Profile
5.4.2 GSK Main Business
5.4.3 GSK Anti-Smoking Products Products, Services and Solutions
5.4.4 GSK Anti-Smoking Products Revenue (US$ Million) & (2018-2023)
5.4.5 GSK Recent Developments
5.5 Takeda pharmaceutical
5.5.1 Takeda pharmaceutical Profile
5.5.2 Takeda pharmaceutical Main Business
5.5.3 Takeda pharmaceutical Anti-Smoking Products Products, Services and Solutions
5.5.4 Takeda pharmaceutical Anti-Smoking Products Revenue (US$ Million) & (2018-2023)
5.5.5 Takeda pharmaceutical Recent Developments
5.6 McNeil AB
5.6.1 McNeil AB Profile
5.6.2 McNeil AB Main Business
5.6.3 McNeil AB Anti-Smoking Products Products, Services and Solutions
5.6.4 McNeil AB Anti-Smoking Products Revenue (US$ Million) & (2018-2023)
5.6.5 McNeil AB Recent Developments
5.7 Revolymer plc
5.7.1 Revolymer plc Profile
5.7.2 Revolymer plc Main Business
5.7.3 Revolymer plc Anti-Smoking Products Products, Services and Solutions
5.7.4 Revolymer plc Anti-Smoking Products Revenue (US$ Million) & (2018-2023)
5.7.5 Revolymer plc Recent Developments
5.8 Imperial Tobacco
5.8.1 Imperial Tobacco Profile
5.8.2 Imperial Tobacco Main Business
5.8.3 Imperial Tobacco Anti-Smoking Products Products, Services and Solutions
5.8.4 Imperial Tobacco Anti-Smoking Products Revenue (US$ Million) & (2018-2023)
5.8.5 Imperial Tobacco Recent Developments
5.9 Elder Pharma
5.9.1 Elder Pharma Profile
5.9.2 Elder Pharma Main Business
5.9.3 Elder Pharma Anti-Smoking Products Products, Services and Solutions
5.9.4 Elder Pharma Anti-Smoking Products Revenue (US$ Million) & (2018-2023)
5.9.5 Elder Pharma Recent Developments
5.10 NJOY
5.10.1 NJOY Profile
5.10.2 NJOY Main Business
5.10.3 NJOY Anti-Smoking Products Products, Services and Solutions
5.10.4 NJOY Anti-Smoking Products Revenue (US$ Million) & (2018-2023)
5.10.5 NJOY Recent Developments
5.11 VMR products
5.11.1 VMR products Profile
5.11.2 VMR products Main Business
5.11.3 VMR products Anti-Smoking Products Products, Services and Solutions
5.11.4 VMR products Anti-Smoking Products Revenue (US$ Million) & (2018-2023)
5.11.5 VMR products Recent Developments
5.12 Lorillard
5.12.1 Lorillard Profile
5.12.2 Lorillard Main Business
5.12.3 Lorillard Anti-Smoking Products Products, Services and Solutions
5.12.4 Lorillard Anti-Smoking Products Revenue (US$ Million) & (2018-2023)
5.12.5 Lorillard Recent Developments
5.13 VaporCorp
5.13.1 VaporCorp Profile
5.13.2 VaporCorp Main Business
5.13.3 VaporCorp Anti-Smoking Products Products, Services and Solutions
5.13.4 VaporCorp Anti-Smoking Products Revenue (US$ Million) & (2018-2023)
5.13.5 VaporCorp Recent Developments
6 North America
6.1 North America Anti-Smoking Products Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Anti-Smoking Products Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Anti-Smoking Products Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Anti-Smoking Products Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Anti-Smoking Products Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Anti-Smoking Products Market Dynamics
11.1 Anti-Smoking Products Industry Trends
11.2 Anti-Smoking Products Market Drivers
11.3 Anti-Smoking Products Market Challenges
11.4 Anti-Smoking Products Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
